Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug
ET HealthWorld - 06 May 2025Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug ...
vertex
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug ...
Big-Name Biotech Dives 10% On A Series Of Setbacks
Investor's Business Daily - 06 May 2025Big-Name Biotech Dives 10% On A Series Of Setbacks ...
Vertex Pharmaceuticals Stock Sinks as Costs Soar
Investopedia - 06 May 2025Vertex Pharmaceuticals Stock Sinks as Costs Soar ...
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss By Stocktwits
Investing.com India - 06 May 2025Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss By Stocktwits ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge
simplywall.st - 06 May 2025Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge ...
Stifel holds Vertex stock with $194 target post-Q1 results
Investing.com - 06 May 2025Stifel holds Vertex stock with $194 target post-Q1 results ...
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
Investopedia - 06 May 2025Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More ...
Leerink cuts Vertex stock rating, lowers price target to $503 By Investing.com
Investing.com India - 06 May 2025Leerink cuts Vertex stock rating, lowers price target to $503 By Investing.com ...
Vertex stock rating downgraded at Wolfe Research
Investing.com - 07 May 2025Vertex stock rating downgraded at Wolfe Research ...
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
The Motley Fool - 11 Apr 2025Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ...
Vertex stock rating downgraded at Wolfe Research By Investing.com
Investing.com India - 07 May 2025Vertex stock rating downgraded at Wolfe Research By Investing.com ...
Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program
Fierce Biotech - 06 May 2025Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program ...
Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia
Fierce Pharma - 06 May 2025Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia ...
Why Vertex Pharmaceuticals Stock Is Down Sharply
Barron's - 06 May 2025Why Vertex Pharmaceuticals Stock Is Down Sharply ...
Recon: FDA names Vinay Prasad as CBER director; Vertex halts trial of mRNA treatment for cystic fibrosis
Regulatory Affairs Professionals Society | RAPS - 06 May 2025Recon: FDA names Vinay Prasad as CBER director; Vertex halts trial of mRNA treatment for cystic fibrosis ...
Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing
GlobeNewswire - 06 May 2025Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing ...
Vertex Sinks On Below-Consensus Revenue, Limited Sales From New Launches
insights.citeline.com - 06 May 2025Vertex Sinks On Below-Consensus Revenue, Limited Sales From New Launches ...
Vertex Reports First Quarter 2025 Financial Results
Business Wire - 05 May 2025Vertex Reports First Quarter 2025 Financial Results ...
Despite Q1 miss, pain drug launch and new CF therapy drive Vertex growth
The Pharma Letter - 06 May 2025Despite Q1 miss, pain drug launch and new CF therapy drive Vertex growth ...